Stephan Bernstein, CEO of GreenRoc, details the PFS results for the new graphite processing plant. Watch the video here.
@pumpky yes, but I don't think a company employee is going to be a trader in HEMO shares and if he was he wouldn't be an employee for long - they invest in shares they feel will provide them good gains in the future and so it's a sign of confidence because they could've put the money into any share on the stock market but they chose their own HEMO
@CD I've seen on a number of shares recently where the bid and ask are the same and sometimes the ask even being a very small percentage higher - not enough to warrant trying to trade it though lol
What I got from the presentation is that there is really big news coming - whether that's exceptional Q1 figures, the extraordinary prospects of West Kenya or a t/o who knows. I'm just excited to be in here - but I do need to somehow free up some funds to top up before the sp gets away from me..! :-S
@saint isn't the 2 week delay due to the lag between becoming infected and dying i.e. not to do with test turnaround times? That's why we had/have to wait a few weeks at a time for each easing measure to ensure it hadn't had a negative impact on the R number.
@nextlink I mean it's not completely out of the question... https://www.takeda.com/49f0c6/siteassets/system/what-we-do/research-and-development-rd-in-takeda/takeda-rd-fact-sheet_final.pdf
Following on from my post this morning about DB's latest Linkedin - because I do think this is worth noting - it's had a comment from the Sales Director at Primerdesign (aka NCYT's lead business):
He said, "The US needs 4M to 5M COVID tests per day get back to any kind of normal."
and DB's response, "A good challenge for us *smiling face with sunglasses*"
For those that keep on here about needing to oust existing companies to get any kind of traction in sales, it looks to me like decent companies (such as GDR and NCYT) are actually supporting each other in the fight against Covid, rather than competing, which makes sense given the scale of this crisis.
Only good times ahead for LTHs imo
@dreamachine I thought you were the machine of dreams, not nightmares.
I honestly don't know how people have so much to speculate about on here; we know the facts from the RNSs, we know the updates from the presentations and we know we're waiting on news which is now much closer than it was 5 weeks ago...
Be patient and hold.
Be aggressive and buy.
Be fearful and sell.
Only worth popping in here after news when we have something decent to discuss, because it's just the same back and forth day-in-day-out here atm
@ethio not sure if you've been in here before but @justhereforhemo put forward a good summary last week for potential investors (and also worth reading up / refreshing on for existing investors). We've also since then inked another agreement with Globalco for R&D for treatment of lupus and other autoimmune diseases - so the collaboration is hotting up.
https://www2.deloitte.com/content/dam/Deloitte/global/Documents/Finance/gx-finance-next-generation-therapies.pdf - This has caused alot of excitement, largely page 8 where it details what other companies have been paid for licencing deals. Our CDX deal with Global Co feels around the 1-3billion mark if you look at similar technologies and target market. Also page 47 seems to imply Orgenesis have either acquired or attempting to acquire Hemogenyx-Cell SA. but this may just refer to the licencing deal...
Here are some comparisons: https://twitter.com/NiSpeach/status/1274411610187186178
Potential take over: https://t.co/wnpLlFj6Y4?amp=1 This got tweeted and retweeted by Vlad, nobody has said officially this is going to happen, just rumour and speculation, however they want to make acquisitions of 1-5bn small pharma with early stage cancer treatments. They are suspected also of being Global Co. If it happens and your a share holder when its announced...
https://twitter.com/justamantrading/status/1274378791511605249?s=20 Companies like J&J sharing our job advertisements
Zak Mir: https://zakmir.wordpress.com/2020/06/16/hemogenyx-hemo-more-than-a-covid-19-gold-rush-play-hemo/
https://www.v o x m a r k e t s.co.uk/articles/escape-hunt-vadim-alexander-of-novacyt-hemogenyx-alan-green-on-avacta-airtel-africa-team17-4c76120/ - 33mins 30secs in, if you have any remaining doubts.
@bench! Nice to see you on here :-)
Definitely great to see the FD topping up at these prices and shows confidence that the 5s are the bottom and hopefully moving up from here. Although I can't see that a ~£25k buy warranted the drop yesterday... anyways, onwards and upwards (I hope!)
@manifesto fingers crossed! It would be nice to be sat in the 6s, or dare I say back in the 7s, ahead of news to give us a better platform to lift off from. As you say patience is needed as it's just a waiting game now
Not sure if this has been shared already but a new post from DB urging the need for more testing in the US:
"People suggesting the US is entering a “second wave“ in COVID-19 infection. I’d argue you need to get to the end of a first phase before you start a second. Countries that do too few tests per confirmed case are unlikely to be testing widely enough to find all cases. The WHO has suggested up to 30 tests per confirmed case as a general benchmark of adequate testing, USA has never passed that benchmark. More testing needed."
https://www.linkedin.com/posts/david-budd-28a25612_people-suggesting-the-us-is-entering-a-second-activity-6683494481209171968-2JT_
@sharebel yes you’re entitled to post useless ramps and warnings of inevitable rises that don’t happen... but expect to be called out on them - hopefully someone else will do that now that I’ve been cowardly filtered for challenging.
We don’t need rampers here to achieve sustained rises, we need medium/long term investors and positive news flow.
@tornadotony you can't really trade this at the moment imo - not for anything worthwhile anyway. They drop the ask but the bid typically stays high, just widening the spread. So you'd have to take a risk that it's going to drop significantly after you sell for the buy back price to be worth the faff and be willing to risk being out on news.
@sharebel I never disagreed with the potential and have already noted that imo HEMO is way undervalued. If you really believe this is being manipulated then I'm sure you believe it's been happening a while, with the sp ranging up and down but without a persistent and sustained rise of late. So based on this previous experience, common sense would suggest you shouldn't post (all points made this morning):
"it is inevitable imho that we move forwards today"
"we are poised to pop and I’m confident that we will do that. A tiny bit of pressure and we will explode!"
"absolutely today - give it a chance. MM’s always exert this type of behaviour to collect. It will rise."
"fully expect to be reaching minimum of high 6’s today"
Expecting the sp to go back above 7p placing price based on the news we've had and the potential isn't ramping, agreed, but the above statements definitely are. You can't blame your statements not being met on MM manipulation - I assume you've been in the game long enough to simply learn not make the statements in the first place..?